| Literature DB >> 31590185 |
Y Dana Neugut1, Sumit Mohan1, Ali G Gharavi1, Krzysztof Kiryluk1.
Abstract
This article discusses potential indications for genetic testing in an African American patient with chronic kidney disease who is being evaluated for a kidney transplant. Two known risk variants in the APOL1 (apolipoprotein L1) gene predispose to kidney disease and are found almost exclusively in persons of African ancestry. APOL1 risk variants are considered, including whether clinicians should incorporate genetic testing in the screening process for living kidney donors. In addition to APOL1 testing, the role of diagnostic exome sequencing in evaluating potential transplant recipients and donors with a positive family history of kidney disease is discussed.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31590185 PMCID: PMC7441647 DOI: 10.7326/M19-1389
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391